MCRB Stock Analysis: Buy, Sell, or Hold?
MCRB - Seres Therapeutics, Inc.
$4.97
-0.27 (-5.07%)
▼
5d:
-6.85%
30d:
-27.09%
90d:
-38.63%
HOLD
MODERATE Confidence
Analysis Updated: Jul 24, 2026 12:00 AM ET
Earnings: Aug 05, 2026
9d
Get Alerted When MCRB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: MCRB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: MCRB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: MCRB is currently trading at $4.96, which is considered oversold relative to its 30-day fair value range of $5.40 to $7.48.
Technical Outlook: Technically, MCRB is in a strong downtrend. The price is currently testing key support at $4.92. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.1% recently.
Market Sentiment: MCRB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $17.00 (+225.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, MCRB is in a strong downtrend. The price is currently testing key support at $4.92. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.1% recently.
Market Sentiment: MCRB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $17.00 (+225.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$5.40 -
$7.48
Company Quality Score
44/100
(HOLD)
Options IV Signal
31th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
56.2%
Protect Your Profits
Holding MCRB? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Options fairly priced (IV 31th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.1%)
- BULLISH: Trading 225.0% below Wall St target ($17.00)
- CAUTION: 5-day price weakness (-6.8%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$5.40 -
$7.48
Current vs Trading Range
OVERSOLD
Expected Move (7 Days)
±$1.00
(20.2%)
Support & Resistance Levels
Support Level
$4.92
Resistance Level
$6.12
Current Trend
Strong Downtrend
Technical data as of
Jul 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.80
Wall Street Target
$17.00
(+225.0%)
Revenue Growth (YoY)
-93.4%
Earnings Growth (YoY)
-91.9%
Share & Embed Analysis
Last updated: July 26, 2026 4:43 AM ET
Data refreshes hourly during market hours. Next update: 5:43 AM
Data refreshes hourly during market hours. Next update: 5:43 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MCRB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$26 | 53 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 57 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$33 | 51 HOLD |
|
ORIC
Oric Pharmaceuticals Inc |
STRONG BUY
12 analysts |
$20 | 57 HOLD |
|
CNTA
Centessa Pharmaceuticals… |
STRONG BUY
11 analysts |
$44 | 61 BUY |
Advanced MCRB Option Strategies
Professional options setups generated by AI based on today's MCRB price and gamma walls.
